Reimbursement of new high cost drugs--funding the unfundable?

Ir Med J. 2010 May;103(5):133.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Drug Costs*
  • Economics, Pharmaceutical*
  • Health Services Accessibility
  • Health Services Research
  • Humans
  • Reimbursement Mechanisms*
  • United Kingdom